Dr. Jim Kellner, a pediatrician and infectious disease expert at the University of Calgary, joins Global’s Joel Senick to discuss the significance of Pfizer-BioNTech’s Phase 3 trial results in children between the ages of 12 and 15.
Canada
COVID-19 vaccine youth trial results are ‘very encouraging,’ according to Calgary pediatrician
More Videos
You are viewing an Accelerated Mobile Webpage.
View Original Article